hypercholesterolemia Archives

Association of Monogenic vs Polygenic Hypercholesterolemia With Risk of Atherosclerotic Cardiovascular Disease.

NewsemiaJanuary 15, 2021

by NewsemiaJanuary 15, 2021012

Related Articles Association of Monogenic vs Polygenic Hypercholesterolemia With Risk of Atherosclerotic Cardiovascular Disease. JAMA Cardiol. 2020 04 01;5(4):390-399 Authors: Trinder M, Francis GA, Brunham...

Cardiology

A Polygenic Risk Score for Low-density Lipoprotein Cholesterol is Associated with Risk of Ischemic Heart Disease and Enriches for Individuals with Familial Hypercholesterolemia.

NewsemiaJanuary 14, 2021

by NewsemiaJanuary 14, 2021013

Related Articles A Polygenic Risk Score for Low-density Lipoprotein Cholesterol is Associated with Risk of Ischemic Heart Disease and Enriches for Individuals with Familial Hypercholesterolemia....

Gastroenterology

An observational study on the effect of hypercholesterolemia developed after living donor liver transplantation on cardiac event and graft failure

NewsemiaJanuary 13, 2021

by NewsemiaJanuary 13, 2021012

An observational study on the effect of hypercholesterolemia developed after living donor liver transplantation on cardiac event and graft failure Source link...

Neurology

LDL Not the Primary Culprit in ASCVD?

NewsemiaDecember 17, 2020

by NewsemiaDecember 17, 202005

LDL cholesterol has been seen as the main offender in ASCVD, but new studies implicate other lipids, including so-called "remnant" cholesterol. An editorial, however, urges...

Neurology

Peripheral Neuropathy Tied to Mortality in Adults Without Diabetes

NewsemiaDecember 12, 2020

by NewsemiaDecember 12, 2020017

Decreased sensation in the foot may be associated with an increased risk of death, even among people with normoglycemia, a study indicates. Medscape Medical News...

Neurology

PFO Closure Beneficial in Stroke Patients With Thrombophilia

NewsemiaDecember 12, 2020

by NewsemiaDecember 12, 202004

Results from what is said to be the largest prospective study on recurrent events in hypercoagulable patients with PFO-associated embolism suggest that PFO closure is...

Algorithm-driven program improves cholesterol, blood pressure levels

NewsemiaNovember 18, 2020

by NewsemiaNovember 18, 2020016

Using a remotely-delivered, algorithm-driven program for disease management, patients experienced significant improvement in cholesterol and blood pressure levels, according to late-breaking research presented today at...

Neurology

Evinacumab, Novel Lipid-Lowerer, Extends Promise in Phase 2 Results

NewsemiaNovember 16, 2020

by NewsemiaNovember 16, 202006

Treatment with evinacumab safely reduced LDL cholesterol levels in patients with treatment-refractory hypercholesterolemia in a multicenter, phase 2 study of 272 patients treated for 16...

Neurology

Vascular Comorbidity in MS Linked to Atrophy, Functional Decline

NewsemiaNovember 6, 2020

by NewsemiaNovember 6, 2020012

People with multiple sclerosis and two vascular comorbidities showed significantly lower gray matter and neurofunctional status vs those with no such comorbidities. Medscape Medical News...

Cardiology

Hidden Burden of Electronic Health Record-Identified Familial Hypercholesterolemia: Clinical Outcomes and Cost of Medical Care.

NewsemiaOctober 16, 2020

by NewsemiaOctober 16, 2020011

Related Articles Hidden Burden of Electronic Health Record-Identified Familial Hypercholesterolemia: Clinical Outcomes and Cost of Medical Care. J Am Heart Assoc. 2019 07 02;8(13):e011822 Authors:...

Cardiology

Atherosclerosis and the Capillary Network; Pathophysiology and Potential Therapeutic Strategies.

NewsemiaSeptember 17, 2020

by NewsemiaSeptember 17, 2020017

Related Articles Atherosclerosis and the Capillary Network; Pathophysiology and Potential Therapeutic Strategies. Cells. 2019 12 24;9(1): Authors: Ziegler T, Abdel Rahman F, Jurisch V, Kupatt...

Worldwide Familial Hypercholesterolemia Market to 2030 – Insight, Epidemiology and Market Forecast – ResearchAndMarkets.com

NewsemiaAugust 28, 2020

by NewsemiaAugust 28, 2020011

DUBLIN–(BUSINESS WIRE)–The “Familial Hypercholesterolemia – Market Insight, Epidemiology and Market Forecast -2030” drug pipelines has been added to ResearchAndMarkets.com’s offering. This report delivers an in-depth...

Gastroenterology

Combo Tx Upped Transplant-Free Survival in Japanese PBC Patients

NewsemiaAugust 28, 2020

by NewsemiaAugust 28, 2020019

(MedPage Today) — Combination therapy with bezafibrate, a fibrate drug used to treat hyperlipidemia, and ursodeoxycholic acid (UDCA) was associated with improved transplant-free survival in...

Cardiology

Failure of cosegregation between a rare STAP1 missense variant and hypercholesterolemia.

NewsemiaAugust 24, 2020

by NewsemiaAugust 24, 2020021

Failure of cosegregation between a rare STAP1 missense variant and hypercholesterolemia. J Clin Lipidol. 2020 Jul 24;: Authors: Mohebi R, Chen Q, Hegele RA, Rosenson...

Cardiology

PCSK9 Inhibitors for Homozygous Familial Hypercholesterolemia: Useful But Seldom Sufficient

NewsemiaJuly 8, 2020

by NewsemiaJuly 8, 2020014

PCSK9 Inhibitors for Homozygous Familial Hypercholesterolemia: Useful But Seldom Sufficient Source link...

Cardiology

Familial Hypercholesterolemia and Lipoprotein(a): Unraveling the Knot That Binds Them

NewsemiaMay 31, 2020

by NewsemiaMay 31, 2020012

Familial Hypercholesterolemia and Lipoprotein(a): Unraveling the Knot That Binds Them Source link...

Cardiology

Ascertainment Bias in the Association Between Elevated Lipoprotein(a) and Familial Hypercholesterolemia

NewsemiaMay 31, 2020

by NewsemiaMay 31, 2020016

AbstractBackground Lipoprotein(a) is an atherogenic low-density lipoprotein–like particle and circulating levels are largely determined by genetics. Patients with familial hypercholesterolemia (FH) have elevated lipoprotein(a); however,...

Cardiology

Familial Hypercholesterolemia: The Most Common Monogenic Disorder in Humans

NewsemiaMay 25, 2020

by NewsemiaMay 25, 2020038

Familial Hypercholesterolemia: The Most Common Monogenic Disorder in Humans Source link...

Cardiology

Worldwide Prevalence of Familial Hypercholesterolemia: Meta-Analyses of 11 Million Subjects

NewsemiaMay 24, 2020

by NewsemiaMay 24, 2020014

AbstractBackground Despite the greater prevalence of familial hypercholesterolemia (FH) in subjects with ischemic heart disease (IHD), premature IHD, and severe hypercholesterolemia (low-density lipoprotein ≥190 mg/dl), overall prevalence...

Cardiology

Molecular diagnosis methods in familial hypercholesterolemia.

NewsemiaMarch 4, 2020

by NewsemiaMarch 4, 2020013

Related Articles Molecular diagnosis methods in familial hypercholesterolemia. Anatol J Cardiol. 2020 Feb;23(3):120-127 Authors: Moldovan V, Banescu C, Dobreanu M Abstract Familial hypercholesterolemia (FH) is...

Using 'federated learning' to enhance predictions of…

Postdoc Position, Neural Regeneration, Echeverri Lab, MBL

A Child with COVID-19 and Immunoglobulin A…

Excellus will pay $5.1M to OCR after…

Double adenoma as a cause of primary…

Patient barriers and facilitators of colonoscopy use:…

Big Discounts with Huge Benefits for People…

CEREBROMAX (acetylcholine chloride, octopamine (hydrochloride), taurine, adenosinum…

Clinical, Genetic, and Disability Profile of Pediatric…

Global Neuronavigation Systems Market to Grow by…

Newsemia

Tag : hypercholesterolemia

Association of Monogenic vs Polygenic Hypercholesterolemia With Risk of Atherosclerotic Cardiovascular Disease.

A Polygenic Risk Score for Low-density Lipoprotein Cholesterol is Associated with Risk of Ischemic Heart Disease and Enriches for Individuals with Familial Hypercholesterolemia.

An observational study on the effect of hypercholesterolemia developed after living donor liver transplantation on cardiac event and graft failure

LDL Not the Primary Culprit in ASCVD?

Peripheral Neuropathy Tied to Mortality in Adults Without Diabetes

PFO Closure Beneficial in Stroke Patients With Thrombophilia

Algorithm-driven program improves cholesterol, blood pressure levels

Evinacumab, Novel Lipid-Lowerer, Extends Promise in Phase 2 Results

Vascular Comorbidity in MS Linked to Atrophy, Functional Decline

Hidden Burden of Electronic Health Record-Identified Familial Hypercholesterolemia: Clinical Outcomes and Cost of Medical Care.

Atherosclerosis and the Capillary Network; Pathophysiology and Potential Therapeutic Strategies.

Worldwide Familial Hypercholesterolemia Market to 2030 – Insight, Epidemiology and Market Forecast – ResearchAndMarkets.com

Combo Tx Upped Transplant-Free Survival in Japanese PBC Patients

Failure of cosegregation between a rare STAP1 missense variant and hypercholesterolemia.

PCSK9 Inhibitors for Homozygous Familial Hypercholesterolemia: Useful But Seldom Sufficient

Familial Hypercholesterolemia and Lipoprotein(a): Unraveling the Knot That Binds Them

Ascertainment Bias in the Association Between Elevated Lipoprotein(a) and Familial Hypercholesterolemia

Familial Hypercholesterolemia: The Most Common Monogenic Disorder in Humans

Worldwide Prevalence of Familial Hypercholesterolemia: Meta-Analyses of 11 Million Subjects

Molecular diagnosis methods in familial hypercholesterolemia.